Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
EBIT Margin

    Back to All Ratios
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year EBIT Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Margin(%) 17.0220.3819.1719.6119.45

What is the latest EBIT Margin ratio of LINCOLN PHARMACEUTICALS ?

The latest EBIT Margin ratio of LINCOLN PHARMACEUTICALS is 17.02 based on Mar2025 Consolidated results.
Year EBIT Margin
Mar202517.02
Mar202420.38
Mar202319.17
Mar202219.61
Mar202119.45

How is EBIT Margin of LINCOLN PHARMACEUTICALS Trending?

Years EBIT Margin % Change
Mar2025 17.02
-16.49
Mar2024 20.38
6.31
Mar2023 19.17
-2.24
Mar2022 19.61
0.82
Mar2021 19.45 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare EBIT Margin ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹966.2 Cr -1.2% -8% -49.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,220.0 Cr 1.2% 2.3% -1.1% Stock Analytics
DIVIS LABORATORIES ₹168,486.0 Cr 0.9% -2.5% 8.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,963.0 Cr 0.5% -1.5% 12.3% Stock Analytics
CIPLA ₹121,751.0 Cr 1.1% -1.6% 4.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,866.0 Cr 2.7% 2.9% 3.3% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-1.2%

-8%

-49.6%

SENSEX

0.1%

0.9%

4.5%


You may also like the below Video Courses